Citation Impact
Citing Papers
A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission
2012
HMGA2 Is a Driver of Tumor Metastasis
2013
Endothelin-1 Promotes Epithelial-to-Mesenchymal Transition in Human Ovarian Cancer Cells
2005
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis
2019
Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: an immunohistochemical study
2008
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin
2007
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
2015 StandoutNobel
Treatment of kidney cancer
2009 StandoutNobel
The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
2017 StandoutNobel
The role of hypoxia-inducible factors in tumorigenesis
2008
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
2011
EGFR Antagonists in Cancer Treatment
2008 Standout
The mechanisms of Hedgehog signalling and its roles in development and disease
2013 Standout
Targeting hypoxia in cancer therapy
2011 Standout
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Adenocarcinomas Arising from Uterine Adenomyosis: A Report of Four Cases
2002 StandoutNobel
Rho GTPase function in tumorigenesis
2009
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity
2012 StandoutNobel
SWI/SNF nucleosome remodellers and cancer
2011 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer
2013 StandoutNobel
Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patients
2010
HYPOXIA AND ANGIOGENESIS IN PANCREATIC CANCER
2006
The semaphorins: versatile regulators of tumour progression and tumour angiogenesis
2008
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
2012 StandoutNobel
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Common pitfalls in preclinical cancer target validation
2017 StandoutNobel
Targeting the hypoxia-inducible factor (HIF) pathway in cancer
2009
Smad7 induces hepatic metastasis in colorectal cancer
2008
Small molecule modulation of HH-GLI signaling: Current leads, trials and tribulations
2010
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c‐Met system via hypoxia inducible factor‐1 in pancreatic cancer
2008
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
2019 StandoutNature
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Targeting endothelial and tumor cells with semaphorins
2007
Modes of resistance to anti-angiogenic therapy
2008 Standout
Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis
2008
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Tumor Angiogenesis
2008 Standout
Multiple renal cancer susceptibility polymorphisms modulate the HIF pathway
2017 StandoutNobel
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Clinical Implications of Extracellular HMGA1 in Breast Cancer
2019
Selective Killing of Hypoxia-Inducible Factor-1–Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
2009 StandoutNobel
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
2012 StandoutNobel
Adipocyte Pseudohypoxia Suppresses Lipolysis and Facilitates Benign Adipose Tissue Expansion
2014 StandoutNobel
Nuclear entry and export of FIH are mediated by HIF1α and exportin1, respectively
2018 StandoutNobel
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
Neuropilins in physiological and pathological angiogenesis
2007
Regulation of ventilatory sensitivity and carotid body proliferation in hypoxia by the PHD2/HIF‐2 pathway
2015 StandoutNobel
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Works of Ryosuke Osada being referenced
Expression of hypoxia-inducible factor 1α, hypoxia-inducible factor 2α, and von Hippel–Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1α is an independent prognostic factor in ovarian carcinoma
2007
Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: An important autocrine/paracrine factor in tumor progression
2006
Elevated expression of E-cadherin and α-, β-, and γ-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas
2004
Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas
2006
Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: It's inhibition leads to growth suppression and apoptosis
2006
Ovarian Yolk Sac Tumor with Endometrioid Carcinoma Arising from Endometriosis in a Postmenopausal Woman, with Special Reference to Expression of α-Fetoprotein, Sex Steroid Receptors, and p53
1998
Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression
2009
Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer
2008